In addition, we found that in the exosomes, exosome marker (CD6, CD9, and Tsg101) expression was abundant (Figure 1(c)), which suggested that the BM-MSC exosomes were successfully isolated in the AML patients or healthy individuals. This evidence concerns the gene CD9 and acute myeloid leukemia.